Esperion Therapeutics
ESPR
#6169
Rank
S$1.14 B
Marketcap
S$4.83
Share price
-1.58%
Change (1 day)
3.57%
Change (1 year)

Earnings for Esperion Therapeutics (ESPR)

Earnings in 2025 (TTM): -S$37.01 Million

According to Esperion Therapeutics's latest financial reports the company's current earnings are S$0.30 Billion. In 2024 the company made an earning of S$9.72 Million, an increase over its 2023 earnings that were of -S$0.2 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Esperion Therapeutics from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$37.01 Million-480.47%
2024 S$9.72 M-104.99%
2023 -S$0.2 Billion-15.03%
2022 -S$0.23 Billion-20.61%
2021 -S$0.29 Billion84.28%
2020 -S$0.16 Billion35.75%
2019 -S$0.12 Billion-55.71%
2018 -S$0.27 Billion19.57%
2017 -S$0.22 Billion125.39%
2016 -S$96.68 Million51.43%
2015 -S$63.85 Million36.45%
2014 -S$46.79 Million43.55%
2013 -S$32.6 Million145.26%
2012 -S$13.29 Million
2002 -S$37.89 Million-7.81%
2001 -S$41.1 Million15.03%
2000 -S$35.73 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ultragenyx Pharmaceutical
RARE
-S$0.68 Billion 1,790.11%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$0.88 B-2,575.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$15.35 B-43,290.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
S$6.66 B-18,849.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
S$6.45 M-118.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-S$88.88 Million 149.91%๐Ÿ‡บ๐Ÿ‡ธ USA